C
Centessa Pharmaceuticals
Merger of ten pharmaceutical companies developing drugs for sleep-wake disorders, neurological conditions and cancer
At a glance
- Status
- Listed
- Listing
- IPO 2021
Open roles
Centessa Pharmaceuticals in the Boston ecosystem
The Centessa Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A14 investors entered at this stage
- BPBVF Partners
Cormorant Asset Management
General Atlantic- LCLogos Capital
- BCBoxer Capital
- SBSamsara BioCapital
T. Rowe Price
Franklin Templeton Investments- ECEcoR1 Capital
- LPLifeSci Venture Partners
Janus Henderson Investors
Wellington Management
Venrock- VVVida Ventures
Source: Dealroom Talent Intelligence.
Patents
43 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Centessa Pharmaceuticals was the backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
10 deals across Centessa Pharmaceuticals's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Centessa Pharmaceuticals's portfolio, mapped.
See Centessa Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Lilly acquires Centessa (June 2026)